Cyclacel Pharmaceuticals, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
CYCC, CYCCP on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Connell Drive, Suite 1500, Berkeley Heights, NJ

There are no Buy or Sell transactions made by insiders since 12/22/2023

Cyclacel Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Spiro Rombotis President and CEO, Director $228K Dec 21, 2023
Kenneth M. Ferguson Director $149K Jun 30, 2023
Karin L. Walker Director $135K Jun 30, 2023
L. Barker Director $134K Jun 30, 2023
Robert J. Spiegel Director $131K Jun 30, 2023
Christopher S. Henney Director $131K Jun 30, 2023
Paul McBarron E. VP, Fin, CFO, COO and Secretary, Director $111K Dec 21, 2023
Lloyd Sems Director $60.3K Jun 14, 2022
Brian Schwartz Interim Chief Medical Officer, Director $50.4K Jan 29, 2024
Gregory T. Hradsky Director $7.87K Jun 15, 2021
Mark Kirschbaum Chief Medical Officer Jun 30, 2023

Recent Insider Transactions by Companies or Individuals for Cyclacel Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.